Doctors Note Logo

Published on: 10/6/2026

Which antibiotics treat plague, and how quickly they must start

Plague is treated with antibiotics such as streptomycin, gentamicin, doxycycline, tetracycline, ciprofloxacin, levofloxacin, moxifloxacin, and chloramphenicol (preferred for plague meningitis), typically given for 10 to 14 days. Antibiotics must be started within 24 hours of the first symptoms, since untreated pneumonic and septicemic plague are nearly always fatal and every hour of delay raises the risk of death. People exposed to plague or in close contact with a pneumonic case may need about 7 days of preventive antibiotics, and drug choice shifts based on age, pregnancy, organ function, and whether the exposure was natural or intentional, so there are several important details to consider below.

Because plague moves fast and its early signs (sudden fever, chills, weakness, swollen tender lymph nodes, cough, or shortness of breath) look like ordinary flu, the hardest part is recognizing when symptoms warrant emergency care rather than rest and fluids. Take a free, instant, online symptom check to clarify what your symptoms may point to and get guidance on the right next step, including how urgently to seek care.

Last reviewed for medical accuracy: 10/06/2026

answer background

Explanation

Plague Antibiotics: Which Ones Work and How Quickly Treatment Must Start

Plague, caused by the bacterium Yersinia pestis, remains a rare but serious disease. Early recognition and prompt antibiotic treatment are critical to reducing the risk of severe complications or death. Below is an overview of the antibiotics that effectively treat plague and guidance on how quickly therapy should begin.

Why Early Treatment Matters

  • Plague can progress rapidly. In its bubonic form, lymph nodes become swollen and tender (buboes). Without treatment, it may advance to septicemic or pneumonic plague, which involve bloodstream infection or lung involvement.
  • Mortality rates rise sharply if antibiotic therapy is delayed beyond 24–48 hours after symptoms appear.
  • Starting the right antibiotic as soon as plague is suspected dramatically improves outcomes.

First-Line Antibiotics

Two aminoglycosides are the gold-standard treatments for plague:

  • Streptomycin

    • Historically the most effective, with proven survival benefits.
    • Typical adult dosage: 15 mg/kg intramuscularly (IM) twice daily.
    • Duration: 10 days minimum, often extended to 14 days for severe cases.
  • Gentamicin

    • Often more available than streptomycin.
    • Typical adult dosage: 5 mg/kg IV once daily or 1.7 mg/kg IM every 8 hours.
    • Duration: 10–14 days, based on clinical response.

Both drugs require careful dosing and monitoring of kidney function and hearing (due to potential toxicity). Hospital administration and laboratory monitoring are standard.

Alternative and Oral Options

When aminoglycosides are unavailable or in less severe cases, these agents have demonstrated effectiveness:

  • Doxycycline

    • A tetracycline antibiotic, effective against both bubonic and pneumonic plague.
    • Adult dosage: 100 mg orally or IV every 12 hours.
    • Treatment length: 10–14 days.
  • Ciprofloxacin (or other fluoroquinolones such as levofloxacin)

    • Good tissue penetration, including lungs in pneumonic plague.
    • Adult dosage: 400 mg IV every 12 hours or 500 mg orally every 12 hours.
    • Duration: 10–14 days.
  • Chloramphenicol

    • Reserved for patients who cannot tolerate the above or for plague meningitis.
    • Adult dosage: 50 mg/kg/day IV in four divided doses.
    • Duration: 10–14 days or longer if central nervous system involvement.

How Quickly Must Treatment Start?

  • Within 24 hours of symptom onset is ideal.
  • If started within the first 24–48 hours, mortality for bubonic plague drops from around 50% (untreated) to below 5–10%.
  • Treatment after 48 hours still provides benefit but carries higher risks of complications and death, particularly for pneumonic plague, which can be rapidly fatal without prompt therapy.

Recognizing Symptoms Early

Early signs can include:

  • Sudden fever and chills
  • Headache and muscle aches
  • Painful, swollen lymph nodes (buboes) in groin, armpit, or neck
  • Rapid breathing or chest discomfort (pneumonic form)
  • Extreme weakness

If you or someone you know has these symptoms—especially after contact with rodents, fleas, or travel to an area with known plague cases—seek medical care immediately. You might also consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.

Supportive Care and Monitoring

Antibiotics are the cornerstone, but additional measures improve recovery:

  • Hydration and electrolyte management to address dehydration and blood pressure changes.
  • Respiratory support (oxygen, ventilation) for pneumonic plague.
  • Fever control with acetaminophen or ibuprofen, unless contraindicated.
  • Isolation precautions: Pneumonic plague can spread between people via respiratory droplets; masks and patient isolation are important.

Special Populations

  • Pregnant women: Streptomycin is avoided due to fetal risk; gentamicin or ciprofloxacin may be used with careful monitoring.
  • Children: Dosing adjustments by weight; aminoglycosides remain first-line, with doxycycline used cautiously in young children (tetracyclines can affect teeth development).
  • Immunocompromised patients: Close monitoring and sometimes combination therapy.

Antibiotic Resistance Considerations

  • Naturally occurring resistance in Y. pestis is rare.
  • Laboratory surveillance continues to monitor for potential resistant strains.
  • If standard therapy fails, combination regimens (e.g., gentamicin plus doxycycline) may be considered under infectious disease specialist guidance.

Follow-Up and Duration of Therapy

  • A full 10–14 day course is standard to ensure the bacteria are fully eradicated.
  • Clinical improvement (fever resolution, shrinking buboes) usually occurs within 48–72 hours of starting antibiotics.
  • If symptoms persist or worsen, further evaluation—and possibly alternative or additional antibiotics—may be necessary.

Key Takeaways

  • Prompt recognition and antibiotic therapy within 24–48 hours of symptom onset can reduce plague mortality from around 50% to under 10%.
  • First-line drugs: streptomycin or gentamicin.
  • Effective alternatives: doxycycline, ciprofloxacin (or levofloxacin), chloramphenicol.
  • Supportive care (fluids, oxygen) and close monitoring are essential, especially for pneumonic plague.
  • Always complete the prescribed course to prevent relapse or resistance.

If you suspect plague or any serious infection, speak to a doctor right away. Early intervention saves lives and reduces complications. For a quick, doctor-approved assessment of your symptoms, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. Do not delay seeking professional medical advice for any condition that could be life threatening or serious.

(References)

  • * Butler T. Plague and tularemia. Pediatr Clin North Am. 1979 May;26(2):355-66. doi: 10.1016/s0031-3955(16)33711-7. PMID: 379779.

  • * Lieberman JM. North American zoonoses. Pediatr Ann. 2009 Apr;38(4):193-8. doi: 10.3928/00904481-20090401-09. PMID: 19455948.

  • * McLellan LK, Hunstad DA. Urinary Tract Infection: Pathogenesis and Outlook. Trends Mol Med. 2016 Nov;22(11):946-957. doi: 10.1016/j.molmed.2016.09.003. Epub 2016 Sep 28. PMID: 27692880; PMCID: PMC5159206.

  • * Sun W. Plague Vaccines: Status and Future. Adv Exp Med Biol. 2016;918:313-360. doi: 10.1007/978-94-024-0890-4_12. PMID: 27722869; PMCID: PMC6559729.

  • * Mohr KI. History of Antibiotics Research. Curr Top Microbiol Immunol. 2016;398:237-272. doi: 10.1007/82_2016_499. PMID: 27738915.

  • * Yang R. Plague: Recognition, Treatment, and Prevention. J Clin Microbiol. 2018 Jan;56(1). doi: 10.1128/JCM.01519-17. Epub 2017 Dec 26. PMID: 29070654; PMCID: PMC5744195.

  • * Demeure CE, Dussurget O, Mas Fiol G, Le Guern AS, Savin C, Pizarro-Cerdá J. Yersinia pestis and plague: an updated view on evolution, virulence determinants, immune subversion, vaccination, and diagnostics. Genes Immun. 2019 May;20(5):357-370. doi: 10.1038/s41435-019-0065-0. Epub 2019 Apr 3. PMID: 30940874; PMCID: PMC6760536.

  • * Orelle C, Mathieu K, Jault JM. Multidrug ABC transporters in bacteria. Res Microbiol. 2019 Nov-Dec;170(8):381-391. doi: 10.1016/j.resmic.2019.06.001. Epub 2019 Jun 25. PMID: 31251973.

  • * Barbieri R, Signoli M, Chevé D, Costedoat C, Tzortzis S, Aboudharam G, Raoult D, Drancourt M. Yersinia pestis: the Natural History of Plague. Clin Microbiol Rev. 2020 Dec 16;34(1). doi: 10.1128/CMR.00044-19. Epub 2020 Dec 9. PMID: 33298527; PMCID: PMC7920731.

  • * Rosenzweig JA, Hendrix EK, Chopra AK. Plague vaccines: new developments in an ongoing search. Appl Microbiol Biotechnol. 2021 Jun;105(12):4931-4941. doi: 10.1007/s00253-021-11389-6. Epub 2021 Jun 18. PMID: 34142207; PMCID: PMC8211537.

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.